Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...
In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...
Lentiviral self-inactivating vectors are the retroviral vectors with the greatest potential for gene therapy Nondividing cells can be transduced by lentiviral vectors. They possess a low ...
SAN DIEGO -- Results from a small single-center study showed that treatment with a gene therapy involving the use of ...
BHUBANESWAR: In a significant medical breakthrough, India's first human gene therapy with a lentiviral vector for severe ...
Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...
India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...
The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 ...
Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the peer-reviewed journal Human Gene Therapy. To improve the efficacy of gene therapy when ...
In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...
manufacturing and analytical testing for leading biopharmaceutical companies engaged in gene therapy and cell therapy projects. With a specific focus on lentiviral vector production, the Company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback